Panel Therapeutic Insights track
Cardiometabolic innovations beyond GLP-1 – Where are we now?
Tue, Nov 10, 2026 · 10:00–10:45 AM CET Therapeutic Insights Stage, Koelnmesse
About this session
The cardiometabolic space is experiencing a surge in innovation beyond GLP-1 therapies, with emerging mechanisms and novel approaches addressing obesity, diabetes, cardiovascular risk, and metabolic health. This session explores what the latest data reveals about next-generation platforms, examines which targets and modalities are capturing scientific and commercial attention, and discusses where capital and partnerships are flowing.
Speakers
-
Partner · LifeArc
Moderator
-
CEO · IsoMab
Panelist
-
Managing Partner · V-Bio Ventures
Panelist
-
Senior Director, Search & Evaluation · Novo
Panelist
-
CEO · Corteria Pharmaceuticals
Panelist